215 related articles for article (PubMed ID: 24550541)
1. Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance.
Farren MR; Carlson LM; Netherby CS; Lindner I; Li PK; Gabrilovich DI; Abrams SI; Lee KP
Sci Signal; 2014 Feb; 7(313):ra16. PubMed ID: 24550541
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y
J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716
[TBL] [Abstract][Full Text] [Related]
3. Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells.
Hix LM; Karavitis J; Khan MW; Shi YH; Khazaie K; Zhang M
J Biol Chem; 2013 Apr; 288(17):11676-88. PubMed ID: 23486482
[TBL] [Abstract][Full Text] [Related]
4. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.
Nefedova Y; Huang M; Kusmartsev S; Bhattacharya R; Cheng P; Salup R; Jove R; Gabrilovich D
J Immunol; 2004 Jan; 172(1):464-74. PubMed ID: 14688356
[TBL] [Abstract][Full Text] [Related]
5. Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.
Yu J; Wang Y; Yan F; Zhang P; Li H; Zhao H; Yan C; Yan F; Ren X
J Immunol; 2014 Sep; 193(5):2574-86. PubMed ID: 25063873
[TBL] [Abstract][Full Text] [Related]
6. Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma.
Alshamsan A
Immunopharmacol Immunotoxicol; 2012 Jun; 34(3):465-9. PubMed ID: 21999714
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.
Nefedova Y; Nagaraj S; Rosenbauer A; Muro-Cacho C; Sebti SM; Gabrilovich DI
Cancer Res; 2005 Oct; 65(20):9525-35. PubMed ID: 16230418
[TBL] [Abstract][Full Text] [Related]
8. A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells.
Yi Z; Li L; Matsushima GK; Earp HS; Wang B; Tisch R
Blood; 2009 Oct; 114(15):3191-8. PubMed ID: 19667404
[TBL] [Abstract][Full Text] [Related]
9. Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
Tkach M; Coria L; Rosemblit C; Rivas MA; Proietti CJ; Díaz Flaqué MC; Beguelin W; Frahm I; Charreau EH; Cassataro J; Elizalde PV; Schillaci R
J Immunol; 2012 Aug; 189(3):1162-72. PubMed ID: 22753933
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
[TBL] [Abstract][Full Text] [Related]
11. Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression.
Farren MR; Carlson LM; Lee KP
Immunol Res; 2010 Mar; 46(1-3):165-76. PubMed ID: 19756409
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor regulates mouse GM-CSF-derived dendritic cell differentiation in vitro.
Zhong L; Yang Q; Xie W; Zhou J
Mol Immunol; 2014 Jul; 60(1):32-43. PubMed ID: 24747959
[TBL] [Abstract][Full Text] [Related]
13. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway.
van Pul KM; Vuylsteke RJCLM; de Beijer MTA; van de Ven R; van den Tol MP; Stockmann HBAC; de Gruijl TD
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33046620
[TBL] [Abstract][Full Text] [Related]
15. p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells.
Che KF; Shankar EM; Muthu S; Zandi S; Sigvardsson M; Hinkula J; Messmer D; Larsson M
Mol Med; 2012 Oct; 18(1):1169-82. PubMed ID: 22777388
[TBL] [Abstract][Full Text] [Related]
16. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis.
Rottenberg ME; Carow B
Semin Immunol; 2014 Dec; 26(6):518-32. PubMed ID: 25458989
[TBL] [Abstract][Full Text] [Related]
17. Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.
Król M; Pawłowski KM; Dolka I; Musielak O; Majchrzak K; Mucha J; Motyl T
Vet Res Commun; 2011 Oct; 35(7):409-23. PubMed ID: 21713436
[TBL] [Abstract][Full Text] [Related]
18. Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration.
Snyder M; Huang XY; Zhang JJ
J Biol Chem; 2011 Nov; 286(45):38886-93. PubMed ID: 21937440
[TBL] [Abstract][Full Text] [Related]
19. STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells.
Okada S; Han S; Patel ES; Yang LJ; Chang LJ
Immunol Cell Biol; 2015; 93(5):461-71. PubMed ID: 25582338
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.
Liu Q; Tan Q; Zheng Y; Chen K; Qian C; Li N; Wang Q; Cao X
J Biol Chem; 2014 Apr; 289(16):11522-11535. PubMed ID: 24627480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
